Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,375 USD | -2,74 % | -10,61 % | -21,45 % |
03/04 | SUTRO BIOPHARMA, INC. : El Piper Sandler continua con su recomendación de compra | ZM |
03/04 | SUTRO BIOPHARMA, INC. : Truist Securities mantiene una recomendación de compra. | ZM |
Resumen de negocios
Número de empleados: 302
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 14/01/09 |
Jane Chung
PSD | President | 53 | 09/08/21 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 31/01/13 |
Steve Michel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Berman
CTO | Chief Tech/Sci/R&D Officer | - | 21/05/20 |
Chief Tech/Sci/R&D Officer | - | 18/09/23 | |
Henry Heinsohn
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anne Borgman
CTO | Chief Tech/Sci/R&D Officer | 56 | 28/02/23 |
Public Communications Contact | 67 | 01/01/08 | |
Werner Rubas
PRN | Corporate Officer/Principal | - | 16/09/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 24/06/19 |
James Panek
BRD | Director/Board Member | 71 | 07/01/20 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
John Freund
BRD | Director/Board Member | 70 | 01/02/14 |
Joseph Lobacki
BRD | Director/Board Member | 65 | 01/02/17 |
William Newell
CEO | Chief Executive Officer | 66 | 14/01/09 |
Michael Dybbs
BRD | Director/Board Member | 49 | 25/07/18 |
Heidi Hunter
BRD | Director/Board Member | 66 | 19/11/21 |
Jon Wigginton
BRD | Director/Board Member | 62 | 30/11/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 75 488 593 | 74 756 129 ( 99,03 %) | 0 | 99,03 % |
Información de la empresa
Sutro Biopharma, Inc.
111 Oyster Point Boulevard
94080, South San Francisco
+650 881 6500
http://www.sutrobio.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-21,45 % | 267 M | |
-3,09 % | 104 mil M | |
+0,82 % | 97,42 mil M | |
+0,79 % | 22,2 mil M | |
-17,84 % | 21,23 mil M | |
-11,11 % | 18,33 mil M | |
-42,83 % | 16,35 mil M | |
-16,55 % | 15,06 mil M | |
+3,94 % | 13,98 mil M | |
+31,92 % | 11,66 mil M |
- Bolsa de valores
- Acciones
- Acción STRO
- Empresa Sutro Biopharma, Inc.